Clinical Trial

Impact and Lived Experience of Parents of a Child With a Large or Giant Congenital Melanocytic Nevus

Study acronym: PANGEA
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to describe the experiences of parents at the birth of a child with a large or giant congenital melanocytic nevus through semi-structured interviews, and to identify potential intervention strategies to improve their care and support.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-12.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-12-22
Trial Details
NCT Number NCT06934759
Lead Sponsor Central Hospital, Nancy, France
Collaborators: Assistance Publique Hopitaux De Marseille, Hôpital Necker-Enfants Malades, Centre Hospitalier Universitaire de Nice, University Hospital, Brest, Annecy Hospital, France, Centre Hospitalier Universitaire Dijon, Nantes University Hospital, University Hospital, Grenoble, Centre Hospitalier Universitaire de la Réunion
Conditions Congenital Melanocytic Nevi, Congenital Melanocytic Nevus, Parent, Psychology, Social
Enrollment 30 participants
Start Date 2025-12-01
Primary Completion 2026-06 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-30